Evidence map›Paper›PMID 41019126›Full record

ArticleACS central science2025

Mesoporous Potassium-Based Metal-Organic Framework as a Drug Carrier.

Bo Fang, Tianyu Shan, Sailing Chen, Fei Pan, Xue Yang, Ding Xiao, Feihe Huang, Zhengwei Mao

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in ACS central science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Bo FangDepartment of Hepatobiliary and Pancreatic Surgery, The Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou 310003, China.
Tianyu ShanStoddart Institute of Molecular Science, Department of Chemistry, Zhejiang University, Hangzhou 310058, China.ORCID https://orcid.org/0009-0004-2031-6835
Sailing ChenDepartment of Reproductive Endocrinology, Women's Hospital, School of Medicine, Zhejiang University, Hangzhou 310006, China.
Fei PanState Key Laboratory of Resource Insects, Institute of Apicultural Research, Chinese Academy of Agricultural Sciences, Beijing 100093, China.
Xue YangStoddart Institute of Molecular Science, Department of Chemistry, Zhejiang University, Hangzhou 310058, China.
Ding XiaoStoddart Institute of Molecular Science, Department of Chemistry, Zhejiang University, Hangzhou 310058, China.ORCID https://orcid.org/0009-0000-0542-3481
Feihe HuangStoddart Institute of Molecular Science, Department of Chemistry, Zhejiang University, Hangzhou 310058, China.ORCID https://orcid.org/0000-0003-3177-6744
Zhengwei MaoDepartment of Hepatobiliary and Pancreatic Surgery, The Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou 310003, China.ORCID https://orcid.org/0000-0001-7990-2856

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

To date, the number of reported mesoporous metal-organic frameworks (MOFs) remains limited. Herein, we report a novel mesoporous potassium-based MOF (K-MOF), designated as

Identifiers

PMID41019126
PMCPMC12464762

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.